Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Ducreux
Quality-Of-Life Findings From a Randomised Phase-Iii Study of XELOX vs FOLFOX-6 in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Catecholamine Production in Patients With Gastroenteropancreatic Neuroendocrine Tumors
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
A Comparative Study of Treatment Toxicities Between FOLFOX 4 and Modified FOLFOX 6 in Iranian Colorectal Cancer Patients
Iranian Journal of Cancer Prevention
Compliance of Patients With Locally Advanced Colorectal Cancer to Chemotherapy Using FOLFOX Compared to XELOX Regimen
The New Ropanasuri Journal of Surgery
A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Oncologist
Cancer Research
Medicine
Oncology
Pcn390 - Metastatic Colorectal Cancer (Mcrc) - Literature Review on Quality of Life Instruments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis
Frontiers in Genetics
Genetics
Molecular Medicine
A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology